We established the UCSF Clinical and Translational Science Institute (CTSI) at the University of California, San Francisco (UCSF) in 2006 to accelerate the pace of research that improves the health ofthe public. The overall mission of CTSI has been to improve and transform clinical and translational research infrastructure and training at UCSF and our partner institutions. In the next funding period we aim to use the substantial knowledge, skills, and infrastructure that we have developed to further accelerate the pace of research at UCSF, to export our successes to other institutions, and to create initiatives aimed at improving the health of our own and other communities, through the following aims:
SPECIFIC AIM 1 : To enhance the highly successful activities of the UCSF CTSI, including the development of new initiatives in the areas of Training, Jnfrastructure/Services, and Advocacy/Culture Change: a) Training: to provide programs for students at all levels, across a spectrum of settings, and including all phases of the improvement of healthcare;b) Infrastructure/Services: to expand services and tools to clinical and translational investigators at UCSF, our partner institutions, and within the broader regional, national, and global communities;and, c) Advocacy/Culture Change: to nurture communication, encourage collaboration, foster innovation, and catalyze the successful conduct of clinical and translational research;to support a diverse faculty;to increase involvement ofthe community and the responsive of research to its needs;and change the academic culture to promote multidisciplinary, collaborative work.
SPECIFIC AIM 2 : To develop crosscutting initiatives using the knowledge, skills, and infrastructure developed by multiple CTSI programs in the first funding period to accelerate clinical and translational research and its impact on health, well beyond the institutions collaborating in the UCSF CTSI. New initiatives will: a) Bring together local public health and philanthropic groups to work with CTSI to improve the health of the San Francisco Bay Area community through a series of health improvement projects directed at high impact conditions;b) create a model system to accelerate the pace of clinical and translational research that includes streamlining regulation, developing participant recruitment services, providing research management, and bringing research services directly into community practices;and, c) improve the performance, transparency and accountability of research administration within and jeyond CTSI by setting challenging goals and tracking performance metrics on public dashboards.
These aims will be achieved by orchestration of activities occurring within and between our 10 programs, supported by a proven governance model, and with strong ties to institutional and community leadership. Our ultimate goal is to bring better health to more people more quickly.
CTSI aims to bring better health to more people more quickly by supporting training, infrastructure, advocacy, and culture change. CTSI achieves this goal not by conducting research but by making it easier for UCSF's superb investigators to conduct research. The current infrastructure and policy environment for clinical and translational research is inefficient, cumbersome and even obstructionist, so CTSI can only meet its goals if it also transforms the way research is done. Its goal is to build innovative infrastructure, tools and services, to transform the core university culture to one which promotes and rewards collaboration and accelerate the clinical application of basic science.
|Grubbs, Vanessa; Vittinghoff, Eric; Taylor, George et al. (2016) The association of periodontal disease with kidney function decline: a longitudinal retrospective analysis of the MrOS dental study. Nephrol Dial Transplant 31:466-72|
|Chan, Alice Y; Punwani, Divya; Kadlecek, Theresa A et al. (2016) A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. J Exp Med 213:155-65|
|Dixit, Shalini; Stein, Phyllis K; Dewland, Thomas A et al. (2016) Consumption of Caffeinated Products and Cardiac Ectopy. J Am Heart Assoc 5:|
|Imber, Brandon S; Kanungo, Ishan; Braunstein, Steve et al. (2016) Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience. Neurosurgery :|
|Young, Chelsea A; Stookey, Jodi; Patel, Anisha I et al. (2016) San Francisco childcare centers' preparedness in the prevention and management of asthma among preschool-aged children. J Asthma 53:691-8|
|Imber, Brandon S; Braunstein, Steve E; Wu, Fred Y et al. (2016) Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J Neurooncol 126:193-200|
|Dixit, Shalini; Pletcher, Mark J; Vittinghoff, Eric et al. (2016) Secondhand smoke and atrial fibrillation: Data from the Health eHeart Study. Heart Rhythm 13:3-9|
|Mansh, M; Binstock, M; Williams, K et al. (2016) Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients. Am J Transplant 16:262-70|
|Kakigi, Caitlin L M; Singh, Kuldev; Wang, Sophia Y et al. (2015) Self-reported Calcium Supplementation and Age-Related Macular Degeneration. JAMA Ophthalmol 133:746-54|
|Nyunt, Myaing M; Nguyen, Vy K; Kajubi, Richard et al. (2015) Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria. Antimicrob Agents Chemother 60:1274-82|
Showing the most recent 10 out of 26 publications